Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Change in Account Payables (2018 - 2026)

Alector's (ALEC) quarterly Change in Account Payables came in at $860000.0 in Q2 2026, up 888.99% year-over-year from $86957.3 in Q2 2025, and up 420.9% quarter-over-quarter from -$268000.0 in Q1 2026.

Analysis

Alector (ALEC) Change in Account Payables (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Change in Account Payables for 9 consecutive years, with $860000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Account Payables rose 888.99% year-over-year to $860000.0 in Q2 2026; TTM through Jun 2026 was $66000.0, a 103.17% increase from a year earlier, with the FY2025 full-year figure at -$524000.0, up 63.64% from the prior year.
  • Change in Account Payables was $860000.0 for Q2 2026 at Alector, up from -$268000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $2.5 million in Q3 2025 and troughed at -$3.1 million in Q4 2025.
  • A 5-year average of -$129000.0 and a median of -$52500.0 in 2023 frame the typical range for Change in Account Payables.
  • Across the five-year window, Change in Account Payables plunged 437.04% in 2023 and surged 17150.0% in 2024, its largest moves.
  • Over 5 years, Change in Account Payables stood at -$189000.0 in 2022, then sank by 437.04% to -$1.0 million in 2023, then plunged by 173.3% to -$2.8 million in 2024, then retreated by 10.53% to -$3.1 million in 2025, then surged by 128.05% to $860000.0 in 2026.
  • The last three Change in Account Payables figures came in at $860000.0 (Q2 2026), -$268000.0 (Q1 2026), and -$3.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn -
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn -8.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn -
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn -
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn -
10 Alector 274.68 Mn 101.88 Mn - 860,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 860,000.00
Mar 31, 2026 -268,000.00
Dec 31, 2025 -3.07 Mn
Sep 30, 2025 2.54 Mn
Jun 30, 2025 -109,000.00
Mar 31, 2025 111,000.00
Dec 31, 2024 -2.77 Mn
Sep 30, 2024 690,000.00
Jun 30, 2024 -275,000.00
Mar 31, 2024 918,000.00
Dec 31, 2023 -1.02 Mn
Sep 30, 2023 4,000.00
Jun 30, 2023 1.55 Mn
Mar 31, 2023 -914,000.00
Dec 31, 2022 -189,000.00
Sep 30, 2022 147,000.00
Jun 30, 2022 -2.57 Mn
Mar 31, 2022 2.04 Mn
Dec 31, 2021 2.26 Mn
Sep 30, 2021 -9.50 Mn